Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Pin to quick picksAvanti Communications Group Plc Fundamentals (AVN)

  • There is currently no data for AVN

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AVN Fundamentals - IFRS

 MillionsMillionsMillionsMillionsMillions
Income Statement31 Dec '1829 Jun '1829 Jun '1729 Jun '1629 Jun '15
Revenue73.7050.0056.6082.8085.20
Operating Profit / Loss(185.50)(43.50)(203.70)(40.00)(32.80)
Net Interest(130.00)(105.20)(93.20)(27.00)(40.50)
Pre tax Profit(6.80)160.00(77.70)(67.00)(73.30)
Post tax Profit(38.20)182.70(65.70)(69.20)(73.30)
Profit for the Period(38.20)182.70(65.70)(69.20)(73.30)
Equity Holders of Parent Company(37.20)183.40(65.20)(68.70)(73.10)
Minority Interests(1.00)(0.70)(0.50)(0.50)(0.20)
      
Continuing EPS     
Earnings per Share (Basic)(2.33USX)35.89p(44.74USX)(49.27USX)(61.50USX)
Earnings per Share (Diluted)(2.33USX)35.37p(44.74USX)(49.27USX)(61.50USX)
Earnings per Share (Adjusted)(2.33USX)35.89p(44.74USX)(49.27USX)(61.50USX)
Continuing and Discontinued EPS     
Earnings per Share (Basic)(2.33USX)35.89p(44.74USX)(49.27USX)(61.50USX)
Earnings per Share (Diluted)(2.33USX)35.37p(44.74USX)(49.27USX)(61.50USX)
Earnings per Share (Adjusted)(2.33USX)35.89p(44.74USX)(49.27USX)(61.50USX)
      
Dividend per Sharen/an/an/an/an/a
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31 Dec '1829 Jun '1829 Jun '1729 Jun '1629 Jun '15
Non-Current Assets     
Intangible Assets9.108.109.3010.8011.00
Property, Plant and Equipment714.40809.80671.80775.10691.00
Investmentsn/an/an/an/an/a
Investment Propertiesn/an/an/an/an/a
Other Financial Assetsn/an/an/an/an/a
Other Non-Current Assetsn/a53.7030.8018.6019.50
 19.5020.202.601.902.60
      
Current Assets     
Inventories19.5020.202.601.902.60
Trade and Other Receivables33.5076.5060.6079.5035.50
Cash at Bank and in Hand24.0011.0032.7056.40122.20
Current Asset Investmentsn/an/an/an/an/a
Other Current Assetsn/an/an/an/an/a
 77.00107.7095.90137.80160.30
      
Other Assetsn/an/an/an/an/a
Total Assets800.50979.30807.80942.30881.80
      
Current Liabilities     
Borrowings1.401.302.103.304.70
Other Current Liabilities61.0073.2070.3082.8031.90
 62.4074.5072.4086.1036.60
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings465.70407.80592.60642.00523.70
Provisions3.60n/an/an/an/a
Other Non-Current Liabilities7.308.109.1012.7016.80
 476.60415.90601.70654.70540.50
      
Net Assets261.50488.90133.70201.50304.70
      
Capital and Reserves     
Share Capital30.6030.602.702.502.40
Share Premium Account1,104.401,104.40519.40515.90505.30
Other Reserves(72.40)(65.90)(67.60)(61.60)(16.50)
Retained Earnings(797.00)(576.40)(317.70)(252.70)(184.40)
Shareholders Funds265.60492.70136.80204.10306.80
      
Minority Interests / Other Equity265.60492.70136.80204.10306.80
Total Equity261.50488.90133.70201.50304.70
      
 31 Dec '1829 Jun '1829 Jun '1729 Jun '1629 Jun '15
Operating Margin(251.70%)(87.00%)(359.89%)(48.31%)(38.50%)
Return on Capital Employed33.80%29.80%2.16%(4.78%)(3.99%)
Dividend Covern/an/an/an/an/a
Dividend Yieldn/an/an/an/an/a
PE Ration/a0.10n/an/an/a
PEGn/an/an/an/an/a
Dividend per Share Growthn/an/an/an/an/a
Net Asset Value per Share$0.12$22.23$0.06$0.09$0.14

Login to your account

Don't have an account? Click here to register.